Opinion

Video

Impact of ADCs on Brain Metastases

Author(s):

Vijayakrishna Gadi, MD, University of Illinois College of Medicine,Susana Campos, MD, MPH

A panel of experts discuss where HER2-directed ADCs antibody-drug conjugates fit into the overall treatment paradigm.

Video content above is prompted by the following:

  • Where do HER2-directed ADCs fit into the overall treatment paradigm? Are most patients being tested for HER2 expression?
    • When and why should T-DXd be considered?
Related Videos
2 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content